The American Journal of Medicine
Volume 119, Issue 3 , Pages 198-202 , March 2006

Aspirin to Prevent Heart Attack and Stroke: What’s the Right Dose?

  • James E. Dalen, MD, MPH

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to James E. Dalen, MD, MPH, University of Arizona, 1840 East River Road, Suite 120, Tucson, AZ 85718.

References 

  1. Dalen JE . An apple a day or an aspirin a day? . Arch Intern Med . 1991;151:1066–1069
  2. Patrano C , Coller B , Fitzgerald GA , et al.   Platelet-active drugs (the relationships among dose, effectiveness and side effects) . Chest . 2004;126:234S–264S
  3. Antithrombotic Trialists’ Collaboration . Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients . BMJ . 2002;324:71–86
  4. Ridker PM , Cook NR , Lee IM , et al.   A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women . N Engl J Med . 2005;352:1293–1304
  5. Hansson L , Zanchetti A , Carruthers SG , et al.   Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension (principal results of the hypertension optimal treatment (HOT) randomised trial) . Lancet . 1998;351:1755–1762
  6. Collaborative Group of the Primary Prevention Project (PPP) . Low-dose aspirin and vitamin E in people at cardiovascular risk (a randomised trial in general practice) . Lancet . 2001;357:89–95
  7. Steering Committee of the Physicians’ Health Study Group . Final report of the aspirin component of the ongoing physicians’ health study . N Engl J Med . 1989;321:129–135
  8. Peto R , Gray R , Collins R , et al.   Randomised trial of prophylactic daily aspirin in British male doctors . BMJ . 1988;296:313–316
  9. Kjeldsen SE , Kolloch RE , Leonetti G , et al.   Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study . J Hypertens . 2000;18:629–642
  10. Diener HC , Cunha L , Forbes C , et al.   European stroke prevention study 2 (dipyridamole and acetylsalicyclic acid in the prevention of stroke) . J Neurol Sci . 1996;143:1–13
  11. Peterson P , Boysen G , Godtfredsen J , et al.   Placebo-controled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation . Lancet . 1989;1:175–179
  12. Stroke Prevention in Atrial Fibrillation Investigators . Stroke prevention in atrial fibrillation study (final results) . Circulation . 1991;84:527–539
  13. Juul-Moller S , Edvardsson N , Jahnmatz B , et al.   Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris . Lancet . 1992;340:1421–1425
  14. Lewis HD , Davis JW , Archibald DG , et al.   Protective effects of aspirin against myocardial infarction and death in men with unstable angina. Results of a Veterans Administration cooperative study . N Engl J Med . 1983;309:396–403
  15. The RISC Group . Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease . Lancet . 1990;336:827–830
  16. ISIS-2 (Second International Study of infarct Survival) Collaborative Group . Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction (ISIS-2) . Lancet . 1988;i:349–360
  17. Diener HC , Cunha L , Forbes C , et al.   European stroke prevention study. 2. dipyridamole and acetylsalicylic acid in the secondary prevention of stroke . J Neurol Sci . 1996;143:1–13
  18. CAST (Chinese Acute Stroke Trial) Collaborative Group . CAST (randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke) . Lancet . 1997;349:1641–1649
  19. Nelson MR , Liew D , Bertram M , et al.   Epidemiological modelling or routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > 70 . BMJ . 2005;330:1306–1311
  20. Serebruany VL , Malinin AI , Eisert RM , et al.   Risk of bleeding complications with antiplatelet agents (meta-analysis of 338191 patients enrolled in 50 randomized controlled trials) . Am J Hematol . 2004;75:40–47
  21. Lee P , Chen W , Ng W , et al.   Low-dose aspirin increases aspirin resistance in patients with coronary artery disease . Am J Med . 2005;118:723–727

PII: S0002-9343(05)01079-X

doi: 10.1016/j.amjmed.2005.11.013

The American Journal of Medicine
Volume 119, Issue 3 , Pages 198-202 , March 2006

Article Tools